Georgetown University Hospital

Washington D.C., District of Columbia 21113

5 studies enrolling now · 139 studies all time

What they study most

Active Idiopathic Inflammatory Myopathy, Acute Alcoholic Hepatitis, Acute Liver Failure, Acute on Chronic Hepatic Failure, Adjustment Disorder, Advanced Cancer, Advanced Prostate Cancer, Advanced or Metastatic Colorectal Cancer, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Alzheimer's Disease, Antisynthetase Syndrome, Any Condition Requiring a PICC Placement

Studies at this site

• A Study of ASP3082 in Adults With Advanced Solid Tumors — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
• A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer — Recruiting now
• A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia — Recruiting now
• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Completed
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma — Running, not enrolling
• A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions — Running, not enrolling
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation — Running, not enrolling
• Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer — Running, not enrolling
• Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease — Completed
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
• A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors — Completed
• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) — Completed
• Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc) — Completed
• 2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C — Running, not enrolling
• A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia — Completed
• Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV — Completed
• A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease — Completed
• A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy — Completed
• A Pivotal Study of the Premia Spine TOPS™ System — Completed
• Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen — Stopped early
• A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis — Stopped early
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) — Completed
• OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure — Stopped early
• Rampart Duo Clinical (RaDical) Post-Market Study — Completed
• Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer — Completed
• A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer — Completed
• Parkinson's Foundation Quality Improvement Initiative — Completed
• Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy — Status unconfirmed
• Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide) — Completed
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) — Completed
• Thrombosomes® in Bleeding Thrombocytopenic Patients — Completed
• A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation — Stopped early
• A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients — Withdrawn before enrolling
• An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) — Completed
• Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery — Status unconfirmed
• Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) — Stopped early
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE — Stopped early
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin — Completed
• Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC — Completed
• An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients — Completed
• SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds — Completed
• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed
• Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI — Status unconfirmed
• Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed